The Mexican healthcare sector faced several challenges in 2018. Budget cuts have limited public sector maneuverability and uncertainty has made many investors cautious in the short-term. While the hurdles have been significant, the Mexican economy remains steady and the local market for pharmaceuticals and medical devices shows no sign of slowing down. With a new administration headed by President-elect Andrés Manuel López Obrador ready to enter office, universal healthcare is at the top of the agenda, along with the need to address the rise in chronic diseases and their management, while adapting regulations to the rapidly changing requirements of a burgeoning technological environment.
